Nota dwar il-lingwa murija
Din il-paġna mhijiex disponibbli fil-lingwa li għażilt permezz tas-servizz ta’ traduzzjoni awtomatika fuq dan is-sit web.
Qed tintwera fil-verżjoni oriġinali bl-Ingliż.
On 29 September 2026, we updated the search paths shown in your browser's address bar to make them easier to read and understand. As a result, links to search results that you previously bookmarked may no longer work. We advise you to carry out your search again.
This Walk-in clinic on CTIS functionalities provides an opportunity for sponsors to receive practical information about the Clinical Trials Information System by asking CTIS experts questions in advance.
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
The Committee for Medicinal Products for Veterinary Use (CVMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning veterinary medicines.